Introduction: This study evaluated the psychometric properties of the newly developed chronic constipation-therapeutic efficacy and satisfaction test (CC-TEST) among patients with chronic constipation. Methods: Japanese patients with moderate or severe chronic constipation underwent a 4-week remedy. The baseline, 2-week, and 4-week assessments included the CC-TEST, Constipation Scoring System (CSS), Medical Outcome Study Short Form-8 Health Survey (SF-8), and Hospital Anxiety and Depression Scale (HADS). The CC-TEST comprises three domains: (1) symptoms; chronic constipation symptom severity (seven items), defecation status (five items), (2) impact for daily life; dissatisfaction with daily life level (DS; four items), and (3) therapeutic response; therapeutic efficacy measured by patients and medication compliance (four items). Results: Of 201 eligible patients at baseline, 110 completed the 4-week treatment and the survey responses. Cronbach’s α values for the stool, defecation, and abdominal symptom subscales, as well as the total symptom score and DS subscale, showed good internal consistency reliability (0.72–0.80). Pearson’s r for comparisons between corresponding items (CC-TEST symptoms with CSS, and CC-TEST DS with SF-8 physical and mental component summary scores) was significant. After 4 weeks, scores for symptoms, defecation status, and DS items/subscales notably decreased, with a significant effect size (p < 0.005, Cohen’s d; 0.30–1.16). Statistically significant differences emerged between treatment responders and nonresponders using the three responder definitions, in changes in scores for most CC-TEST symptoms, defecation status, and DS items/subscales (p < 0.05). Conclusion: CC-TEST demonstrates commendable reliability, convergent and known-group validity, and responsiveness to treatment effects. As a simple, comprehensive, and versatile patient-reported outcome measure, CC-TEST may be well suited for clinical trials and primary care of Japanese patients with chronic constipation.

1.
Ogasawara
N
,
Funaki
Y
,
Kasugai
K
,
Ebi
M
,
Tamura
Y
,
Izawa
S
, et al
.
Overlap between constipation and gastroesophageal reflux disease in Japan: results from an internet survey
.
J Neurogastroenterol Motil
.
2022
;
28
(
2
):
291
302
.
2.
Belsey
J
,
Greenfield
S
,
Candy
D
,
Geraint
M
.
Systematic review: impact of constipation on quality of life in adults and children
.
Aliment Pharmacol Ther
.
2010
;
31
(
9
):
938
49
.
3.
Flourié
B
,
Not
D
,
François
C
,
Prost à la Denise
M
.
Factors associated with impaired quality of life in French patients with chronic idiopathic constipation: a cross-sectional study
.
Eur J Gastroenterol Hepatol
.
2016
;
28
(
5
):
525
31
.
4.
Ohkubo
H
,
Yoshihara
T
,
Misawa
N
,
Ashikari
K
,
Fuyuki
A
,
Matsuura
T
, et al
.
Relationship between stool form and quality of life in patients with chronic constipation: an internet questionnaire survey
.
Digestion
.
2021
;
102
(
2
):
147
54
.
5.
Tomita
T
,
Kazumori
K
,
Baba
K
,
Zhao
X
,
Chen
Y
,
Miwa
H
.
Impact of chronic constipation on health-related quality of life and work productivity in Japan
.
J Gastroenterol Hepatol
.
2021
;
36
(
6
):
1529
37
.
6.
Chang
JY
,
Locke
GR
3rd
,
McNally
MA
,
Halder
SL
,
Schleck
CD
,
Zinsmeister
AR
, et al
.
Impact of functional gastrointestinal disorders on survival in the community
.
Am J Gastroenterol
.
2010
;
105
(
4
):
822
32
.
7.
US Department of Health and Human Services
.
Food and Drug administration, center for Drug evaluation and research, center for biologics evaluation and research, center for devices and radiological health. Guidance for industry
. In:
Patient-reported outcomes measures: use in medical product development to support labeling claims
.
8.
Research Society for the Diagnosis and Treatment of Chronic Constipation/Affiliated to the Japanese Society of Gastroenterology
.
Evidence-based clinical practice guideline for chronic constipation 2017
.
Tokyo
:
Nankodo
;
2017
. (in Japanese).
9.
Nakada
K
,
Isshi
K
,
Manabe
N
.
How to measure quality of life in patients with chronic constipation?
In:
Nakajima
A
,
Maeda
K
, editors.
Constipation and fecal incontinence practice Q&A for the family physician
.
Nippon Ijishinpou Co., Ltd
;
2019
. p.
39
43
. (in Japanese).
10.
Agachan
F
,
Chen
T
,
Pfeifer
J
,
Reissman
P
,
Wexner
SD
.
A constipation scoring system to simplify evaluation and management of constipated patients
.
Dis Colon Rectum
.
1996
;
39
(
6
):
681
5
.
11.
Ohkubo
H
,
Nakajima
A
.
Intractable chronic constipation
.
J Jpn Soc Intern Med
.
2013
;
102
(
1
):
83
9
. (in Japanese).
12.
Turner-Bowker
DM
,
Bayliss
MS
,
Ware
JE
Jr.
,
Kosinski
M
.
Usefulness of the SF-8 Health Survey for comparing the impact of migraine and other conditions
.
Qual Life Res
.
2003
;
12
(
8
):
1003
12
.
13.
Zigmond
AS
,
Snaith
RP
.
The hospital anxiety and depression scale
.
Acta Psychiatr Scand
.
1983
;
67
(
6
):
361
70
.
14.
Heaton
KW
,
Radvan
J
,
Cripps
H
,
Mountford
RA
,
Braddon
FE
,
Hughes
AO
.
Defecation frequency and timing, and stool form in the general population: a prospective study
.
Gut
.
1992
;
33
(
6
):
818
24
.
15.
Cohen
J
.
A power primer
.
Psychol Bull
.
1992
;
112
(
1
):
155
9
.
16.
Frank
L
,
Kleinman
L
,
Farup
C
,
Taylor
L
,
Miner
P
Jr
.
Psychometric validation of a constipation symptom assessment questionnaire
.
Scand J Gastroenterol
.
1999
;
34
(
9
):
870
7
.
17.
Knowles
CH
,
Scott
SM
,
Legg
PE
,
Allison
ME
,
Lunniss
PJ
.
Level of classification performance of KESS (symptom scoring system for constipation) validated in a prospective series of 105 patients
.
Dis Colon Rectum
.
2002
;
45
(
6
):
842
3
.
18.
Marquis
P
,
De La Loge
C
,
Dubois
D
,
McDermott
A
,
Chassany
O
.
Development and validation of the patient assessment of constipation quality of life questionnaire
.
Scand J Gastroenterol
.
2005
;
40
(
5
):
540
51
.
19.
Varma
MG
,
Wang
JY
,
Berian
JR
,
Patterson
TR
,
McCrea
GL
,
Hart
SL
.
The constipation severity instrument: a validated measure
.
Dis Colon Rectum
.
2008
;
51
(
2
):
162
72
.
20.
Wang
JY
,
Hart
SL
,
Lee
J
,
Berian
JR
,
McCrea
GL
,
Varma
MG
.
A valid and reliable measure of constipation-related quality of life
.
Dis Colon Rectum
.
2009
;
52
(
8
):
1434
42
.
21.
Spiegel
B
,
Camilleri
M
,
Bolus
R
,
Andresen
V
,
Chey
WD
,
Fehnel
S
, et al
.
Psychometric evaluation of patient-reported outcomes in irritable bowel syndrome randomized controlled trials: a Rome Foundation report
.
Gastroenterology
.
2009
;
137
(
6
):
1944
53.e533
.
22.
Irvine
EJ
,
Tack
J
,
Crowell
MD
,
Gwee
KA
,
Ke
M
,
Schmulson
MJ
, et al
.
Design of treatment trials for functional gastrointestinal disorders
.
Gastroenterology
.
2016
;
150
(
6
):
1469
80.e1
.
23.
Ritter
PL
,
González
VM
,
Laurent
DD
,
Lorig
KR
.
Measurement of pain using the visual numeric scale
.
J Rheumatol
.
2006
;
33
(
3
):
574
80
.
24.
US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER)
.
Guidance for industry: irritable bowel syndrome clinical evaluation of drugs for treatment
.
2012
.
25.
Johanson
JF
,
Wald
A
,
Tougas
G
,
Chey
WD
,
Novick
JS
,
Lembo
AJ
, et al
.
Effect of tegaserod in chronic constipation: a randomized, double-blind, controlled trial
.
Clin Gastroenterol Hepatol
.
2004
;
2
(
9
):
796
805
.
26.
Kamm
MA
,
Müller-Lissner
S
,
Talley
NJ
,
Tack
J
,
Boeckxstaens
G
,
Minushkin
ON
, et al
.
Tegaserod for the treatment of chronic constipation: a randomized, double-blind, placebo-controlled multinational study
.
Am J Gastroenterol
.
2005
;
100
(
2
):
362
72
.
27.
Nakajima
A
,
Taniguchi
S
,
Kurosu
S
,
Gillberg
PG
,
Mattsson
JP
,
Camilleri
M
.
Efficacy, long-term safety, and impact on quality of life of elobixibat in more severe constipation: post hoc analyses of two phase 3 trials in Japan
.
Neurogastroenterol Motil
.
2019
;
31
(
5
):
e13571
.
28.
Saito
Y
,
Yokota
T
,
Arai
M
,
Tada
Y
,
Sumitani
M
.
Naldemedine in Japanese patients with opioid-induced constipation and chronic noncancer pain: open-label Phase III studies
.
J Pain Res
.
2019
;
12
:
127
38
.
29.
Christensen
P
,
Bazzocchi
G
,
Coggrave
M
,
Abel
R
,
Hultling
C
,
Krogh
K
, et al
.
A randomized, controlled trial of transanal irrigation versus conservative bowel management in spinal cord-injured patients
.
Gastroenterology
.
2006
;
131
(
3
):
738
47
.
30.
Numata
T
,
Takayama
S
,
Tobita
M
,
Ishida
S
,
Katayose
D
,
Shinkawa
M
, et al
.
Traditional Japanese medicine daikenchuto improves functional constipation in poststroke patients
.
Evid Based Complement Alternat Med
.
2014
;
2014
:
231258
.
31.
Choi
HI
,
Cha
JM
,
Jeong
IK
,
Cho
IJ
,
Yoon
JY
,
Kwak
MS
, et al
.
Efficacy and safety of Gelidium elegans intake on bowel symptoms in obese adults: a 12-week randomized double-blind placebo-controlled trial
.
Medicine
.
2019
;
98
(
17
):
e14981
.
32.
Taniguchi
TM
,
Abreu
GE
,
Portugal
MM
,
Barroso Junior
U
.
Cross-cultural adaptation and validation of the constipation scoring system for the brazilian population
.
Arq Gastroenterol
.
2022
;
59
(
1
):
3
8
.
33.
Jaeschke
R
,
Singer
J
,
Guyatt
GH
.
A comparison of seven-point and visual analogue scales. Data from a randomized trial
.
Control Clin Trials
.
1990
;
11
(
1
):
43
51
.
34.
Dubois
D
,
Gilet
H
,
Viala-Danten
M
,
Tack
J
.
Psychometric performance and clinical meaningfulness of the Patient Assessment of Constipation-Quality of Life questionnaire in prucalopride (RESOLOR) trials for chronic constipation
.
Neurogastroenterol Motil
.
2010
;
22
(
2
):
e54
63
.
35.
Kamm
MA
,
Mueller-Lissner
S
,
Wald
A
,
Richter
E
,
Swallow
R
,
Gessner
U
.
Oral bisacodyl is effective and well-tolerated in patients with chronic constipation
.
Clin Gastroenterol Hepatol
.
2011
;
9
(
7
):
577
83
.
36.
Zhang
B
,
Ding
JH
,
Zhao
YJ
,
Zhang
M
,
Yin
SH
,
Feng
YY
, et al
.
Midterm outcome of stapled transanal rectal resection for obstructed defecation syndrome: a single-institution experience in China
.
World J Gastroenterol
.
2013
;
19
(
38
):
6472
8
.
37.
Bengi
G
,
Yalçın
M
,
Akpınar
H
,
Keskinoğlu
P
,
Ellidokuz
H
.
Validity and reliability of the patient assessment of constipation quality of life questionnaire for the Turkish population
.
Turk J Gastroenterol
.
2015
;
26
(
4
):
309
14
.
38.
Nomura
H
,
Agatsuma
T
,
Mimura
T
.
Validity and reliability of the Japanese version of the patient assessment of constipation quality of life questionnaire
.
J Gastroenterol
.
2014
;
49
(
4
):
667
73
.
39.
Tsunoda
A
,
Yamada
K
,
Takano
M
,
Kusanagi
H
.
The translation and validation of the Japanese version of the patient assessment of constipation quality of life scale
.
Surg Today
.
2016
;
46
(
4
):
414
21
.
You do not currently have access to this content.